M&A Deal Summary |
|
|---|---|
| Date | 2021-11-02 |
| Target | Meridian Medical Technologies |
| Sector | Life Science |
| Buyer(s) | Altaris |
| Sellers(s) | Pfizer |
| Deal Type | Divestiture |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Private Equity Firm |
|---|---|
| Founded | 2003 |
| PE ASSETS | 10.0B USD |
| Size | Mega |
| Type | Sector Focused |
Altaris is a specialist private equity firm that targets investments in the healthcare industry. Altaris focuses its investment activity across the healthcare sector, including pharmaceuticals, medical devices, healthcare services and healthcare IT. Altaris will consider both control and non-control investment situations requiring $15 to $50 million of equity capital. Prospective investment situations include corporate carve-outs, leveraged buyouts, and growth equity/recapitalization investments. Altaris was formed in 2004 and is based in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 32 of 36 |
| Sector (Life Science) | 6 of 8 |
| Type (Divestiture) | 4 of 6 |
| State (Missouri) | 1 of 1 |
| Country (United States) | 30 of 34 |
| Year (2021) | 3 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-09-23 |
BK Medical
Peabody, Massachusetts, United States BK Medical is a global intraoperative imaging and surgical navigation company. BK Medical enables surgeons to make real-time, data-based decisions during surgical procedures, resulting in better clinical outcomes and reduced costs for patients, physicians, and the healthcare system. BK Medical is based in Peabody, Massachusetts. |
Sell | $1.5B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-12-17 |
Veranova
Wayne, Pennsylvania, United States Veranova is a developer and manufacturer of specialist and complex active pharmaceutical ingredients for pharma and biotech companies. Veranova was founded in 1970 and is based in Wayne, Pennsylvania. |
Buy | £325M |
| Category | Company |
|---|---|
| Founded | 1849 |
| Sector | Life Science |
| Employees | 8,300 |
| Revenue | 58.5B USD (2023) |
Pfizer is a global pharmaceutical company that is involved in the discovery, development, manufacture, and marketing of a wide range of healthcare products, including medicines and vaccines. The company's portfolio includes treatments across a broad spectrum of areas such as oncology, cardiology, neurology, and infectious diseases, among others. Pfizer was founded in 1849 and is based in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 18 of 18 |
| Sector (Life Science) | 13 of 13 |
| Type (Divestiture) | 15 of 15 |
| State (Missouri) | 1 of 1 |
| Country (United States) | 13 of 13 |
| Year (2021) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-04-28 |
Amplyx
San Diego, California, United States Amplyx is a provider in the development of therapies for debilitating and life-threatening diseases that affect people with compromised immune systems. Amplyx’s lead compound, Fosmanogepix (APX001), is a novel investigational asset under development for the treatment of invasive fungal infections. Amplyx was founded in 2006 and is based in San Diego, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-12-13 |
Arena Pharmaceuticals
San Diego, California, United States Arena Pharmaceuticals is a clinical-stage company developing innovative potential therapies for the treatment of several immuno-inflammatory diseases. Arena Pharmaceuticals was incorporated in 1997 and is based in San Diego, California. |
Buy | $6.7B |
